Thomas Flaten
Stock Analyst at Lake Street
(0.72)
# 3,728
Out of 4,754 analysts
34
Total ratings
22.86%
Success rate
-17.68%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVAX Evaxion Biotech | Maintains: Buy | $35 → $6 | $1.89 | +217.46% | 2 | Feb 4, 2025 | |
| OPTN OptiNose | Maintains: Buy | $45 → $17 | $5.27 | +222.58% | 4 | Jan 16, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $4.11 | +118.98% | 2 | Jan 8, 2025 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $4 → $7 | $2.57 | +172.90% | 4 | Dec 16, 2024 | |
| CSTL Castle Biosciences | Maintains: Buy | $34 → $40 | $21.27 | +88.06% | 5 | Nov 5, 2024 | |
| DERM Journey Medical | Initiates: Buy | $9 | $5.05 | +78.22% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.77 | +289.61% | 3 | Mar 12, 2024 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $3 → $8 | $2.65 | +201.89% | 1 | Mar 7, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.85 | +285.96% | 3 | Mar 5, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $24.51 | +2.00% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $10 | $2.78 | +259.71% | 4 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $5.33 | +26,916.89% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $6.21 | +28.82% | 1 | Jul 7, 2022 |
Evaxion Biotech
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $1.89
Upside: +217.46%
OptiNose
Jan 16, 2025
Maintains: Buy
Price Target: $45 → $17
Current: $5.27
Upside: +222.58%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.11
Upside: +118.98%
Checkpoint Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $4 → $7
Current: $2.57
Upside: +172.90%
Castle Biosciences
Nov 5, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $21.27
Upside: +88.06%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $5.05
Upside: +78.22%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.77
Upside: +289.61%
Aquestive Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $3 → $8
Current: $2.65
Upside: +201.89%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.85
Upside: +285.96%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $24.51
Upside: +2.00%
Dec 1, 2022
Downgrades: Hold
Price Target: $60 → $10
Current: $2.78
Upside: +259.71%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $5.33
Upside: +26,916.89%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $6.21
Upside: +28.82%